We’re working with our partners to identify more unmet medical needs and focus our research where it is needed most. Our growing pipeline includes first-in-class therapies aimed at providing new solutions and cancer support where no options currently exist, and helping to lift the burden of cancer for patients.

Clinical Research

We are committed to clinical research with a program of 21 trials from Phase I to III with more than 6,500 patients in 747 centers globally between 2014 and 2016.

pipeline sito 1pipeline sito 3